-cystic fibrosis and treatment started virtually from birth, yet only one of this small group is in Group 1. Two are in Group 2, and one has died of pneumonia at the age of 10 months. The figures are small but nevertheless show that early recognition and treatment is not the only factor affecting ptrognosis. The following papers were also read:
REFERENCES
Exeter Community Medicine Professor J R Ashford ( This child appears to be a typical case of the salt-losing type of the adrenogenital syndrome presumably due to 21-hydroxylase deficiency.
Case 2 M R, boy aged 6 days Born normally at 38 weeks gestation, weighing 3-5 kg (7 lb 12 oz). He was seen at the age of 6 days with a two-day history of poor feeding and weight loss of 250 g (9 oz). He looked ill. His scrotum was pigmented. His blood pressure was 118 mmHg by the flush method. His critical illness did not permit extensive investigations. Serum urea 112 mg/100 ml; serum sodium 112, potassium 10-6, chloride 104, bicarbonate 11 mEq/l. A 14-hour urine specimen contained 6-4 pg 11-hydroxycorticosteroids and 0-006 mg pregnanetriol; urine 11-oxygenation ratio 0 14: 1.
He was treated with hydrocortisone, 9a-fluorohydrocortisone and added salt. Until the age of 4 months his management was difficult and he showed a tendency to fluid retention. Since then Table 1 Results of ACTH stimulation test
Baseline
Day 3 Day 4
Plasma I l-hydroxycorticosteroids (g±g/100 ml) 6 5 (9 a.m.) 16-3 (6 hours post-Synacthen Patrizk & Lake (1969, 1970) carried out enzyme studies and concluded that the condition results from a deficiency of a lysosomal acid lipase responsible for the degradation of triglycerides and cholesteryl esters, and have also demonstrated the enzyme defect histochemically as a deficiency of E 600-resistant acid esterase. Young & Patrick (personal communication) have applied a sensitive method of assay, em-
